Market for Adult Patient Simulator Segment to Grow atHighest CAGR during 2020-2027
According to the latest study on “North America Patient Simulators Market Forecast to 2027- COVID-19 Impact and Country Analysis- by product and end user” the market was valued at US$403.51 million in 2019 and is projected to reach US$1,503.65 million by 2027; it is expected to grow at a CAGR of 18.0% during 2020-2027. The report highlights trends prevailing in the North America patient simulators market, and the drivers and restraints pertaining to the market growth.
Based on product, the North America patient simulators market is segmented into infant simulator, childbirth simulator, and adult patient simulator. The adult patient simulator segment held the largest share of the market in 2019, and it isestimated to register the highest CAGR during the forecast period. The growth of the market for this segment isdriven by the availability of a wide range of high-fidelity manikins in the market. Moreover, the patient simulators hold huge potential to help in managing the COVID-19 crisis, as well as other future pandemics. Simulators can be usedto scale up workforce capacity through experimental learning. Also, simulation rapidly facilitates hospital preparation as well as education of large numbers of healthcare professionals and students.
The growth of the North America patient simulators market is attributed to increasing demand for minimally invasive treatment methods, growing technological advancements, and rising focus on patient safety. However, the high cost of patient simulators restrains the growth of the market.CAE Inc.; Laerdal Medical; 3D Systems, Inc.; Gaumard Scientific; Kyoto Kagaku Co., Ltd.; Simulab Corporation; Simulaids; Surgical Science; Mentice AB; and Limbs & Things LTD are among the leading companies operating in the North America patient simulators market.
The report segments North America patient simulators market as follows:
By Product
By End User
By Country
Reasons to Buy
According to the latest study on “North America Patient Simulators Market Forecast to 2027- COVID-19 Impact and Country Analysis- by product and end user” the market was valued at US$403.51 million in 2019 and is projected to reach US$1,503.65 million by 2027; it is expected to grow at a CAGR of 18.0% during 2020-2027. The report highlights trends prevailing in the North America patient simulators market, and the drivers and restraints pertaining to the market growth.
Based on product, the North America patient simulators market is segmented into infant simulator, childbirth simulator, and adult patient simulator. The adult patient simulator segment held the largest share of the market in 2019, and it isestimated to register the highest CAGR during the forecast period. The growth of the market for this segment isdriven by the availability of a wide range of high-fidelity manikins in the market. Moreover, the patient simulators hold huge potential to help in managing the COVID-19 crisis, as well as other future pandemics. Simulators can be usedto scale up workforce capacity through experimental learning. Also, simulation rapidly facilitates hospital preparation as well as education of large numbers of healthcare professionals and students.
The growth of the North America patient simulators market is attributed to increasing demand for minimally invasive treatment methods, growing technological advancements, and rising focus on patient safety. However, the high cost of patient simulators restrains the growth of the market.CAE Inc.; Laerdal Medical; 3D Systems, Inc.; Gaumard Scientific; Kyoto Kagaku Co., Ltd.; Simulab Corporation; Simulaids; Surgical Science; Mentice AB; and Limbs & Things LTD are among the leading companies operating in the North America patient simulators market.
The report segments North America patient simulators market as follows:
By Product
- Adult Patient Simulator
- Infant Simulator
- Childbirth Simulator
By End User
- Academic Institutes
- Hospitals
- Military Organizations
By Country
- US
- Canada
- Mexico
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America patient simulators market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America patient simulators market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Patient Simulators Market - Market Landscape
5. North America Patient Simulators Market - Key Market Dynamics
6. Patient Simulators Market - North America Analysis
7. North America Patient Simulators Market Analysis - By Product
8. North America Patient Simulators Market Analysis - By End User
9. North America Patient Simulators Market Revenue and Forecasts to 2027
10. Impact of COVID-19 Pandemic on North America Patient Simulators Market
11. Patient Simulators Market - Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- CAE Inc.
- Laerdal Medical
- 3D Systems, Inc.
- Gaumard Scientific
- Kyoto Kagaku Co., Ltd.
- Simulab Corporation
- Simulaids
- Surgical Science
- Mentice AB
- Limbs & Things LTD
